Table 4. Frequencies of complications and average time to development of both procedures.
| Complications of IBT | n=53 (%) | Average time to development in months |
|---|---|---|
| Radiation-induced retinopathya | 24 (45.3) | 20.8±10.6 (4.3–46.3) |
| Neovascular glaucomaa | 15 (28.3) | 25.6±11.7 (11.9–63.5) |
| Macular oedemaa | 13 (24.5) | 19.2±13.8 (11.3–43.2) |
| Vitreous haemorrhagea | 12 (22.6) | 29.0±16.3 (7.7–63.3) |
| Radiation-induced cataracta | 9 (17.0) | 11.3±5.9 (3.6–20.7) |
| Recurrent exudative retinal detachmenta | 7 (13.2) | 14.0±9.4 (4.0–28.5) |
| Scleral necrosisa | 4 (7.5) | 19.2±6.43 (11.3–26.3) |
| Complications of TSRWH | n=19 (%) | Average time to development in months |
| Rhegmatogenous retinal detachmenta | 4 (21.1) | 2.3±1.8 (0.23–3.0) |
| Ocular hypertensiona | 4 (21.1) | 1.3±0.24 (0.14–2.3) |
| Submacular haemorrhageb | 3 (15.8) | — |
| Corneal oedemac | 2 (10.5) | 10.1 (8.74–11.43) |
| Epiretinal membranec | 2 (10.5) | 12.2 (6.2–18.3) |
| Secondary glaucomac | 2 (10.5) | 19.3 (13.4–25.2) |
| Silicone oil emulsification (anterior chamber)c | 2 (10.5) | 3.9 (2.1–5.8) |
Abbreviations: IBT, iodine-125 brachytherapy; TSRWH, transscleral resection performed without hypotensive anaesthesial.
a
Mean±SD (range).
b
Perioperative complication.
c
Mean (range).